Mark Klinger
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 18
- T-cell and B-cell Immunology 9
- Immune Cell Function and Interaction 9
- Immunotherapy and Immune Responses 7
- Immunodeficiency and Autoimmune Disorders 3
- Co-authors
- Malek Faham (16 shared papers)Lawrence Fong (5 shared papers)Yafei Hou (3 shared papers)Craig Cummings (3 shared papers)Antoni Ribas (3 shared papers)Edward Cha (3 shared papers)Robert J. Kay (5 shared papers)Nigel Killeen (5 shared papers)
- Journals
- The Journal of Immunology (4 papers)Journal of Clinical Oncology (4 papers)Blood (4 papers)Oncogene (3 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Mark Klinger
30 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 79
- Immunology 872
- Oncology 696
- Hematology 274
- Cancer Research 200
- Genetics 127
Countries citing papers authored by Mark Klinger
This map shows the geographic impact of Mark Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Klinger more than expected).
Fields of papers citing papers by Mark Klinger
This network shows the impact of papers produced by Mark Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Klinger. The network helps show where Mark Klinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Klinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 291 | |
| 2 | 2017 | 287 | |
| 3 | 2016 | 173 | |
| 4 | 2014 | 101 | |
| 5 | 2001 | 96 | |
| 6 | 2012 | 89 | |
| 7 | 2015 | 74 | |
| 8 | 2016 | 71 | |
| 9 | 2000 | 63 | |
| 10 | 2009 | 57 | |
| 11 | 2006 | 52 | |
| 12 | 2008 | 50 | |
| 13 | 2013 | 47 | |
| 14 | 2009 | 46 | |
| 15 | 2015 | 40 | |
| 16 | 2004 | 33 | |
| 17 | 2013 | 29 | |
| 18 | 2003 | 26 | |
| 19 | 2015 | 15 | |
| 20 | 2010 | 15 |
About Mark Klinger
Mark Klinger is a scholar working on Immunology, Molecular Biology, Oncology, Genetics and Hematology, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Immunology (872 citations), Oncology (696 citations), Hematology (274 citations), Cancer Research (200 citations) and Genetics (127 citations). Mark Klinger has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Malek Faham, Lawrence Fong, Yafei Hou, Craig Cummings, Antoni Ribas, Edward Cha, Robert J. Kay, Nigel Killeen, Jianbiao Zheng and Ryan Emerson. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Blood, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.